Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

LEUKOSCAN DIN 02329255

Status: Cancelled Pre Market
Holder: IMMUNOMEDICS, INC.
Molecule: SULESOMAB

Health Canada record

Active ingredient(s)SULESOMAB 0.31 MG
Dosage formPowder For Solution
RouteIntravenous
ScheduleSCHEDULE C
ClassRadiopharmaceutical
ATC
Original market date
Current status date06-Sep-2022
SourceHealth Canada DPD

Establishment licence of the holder

Immunomedics, Inc. — licence , not currently licensed, last inspection rating C (2020-03-02).

No Canadian shortage report is currently matched to this DIN.

Request a quote for LEUKOSCAN

How to read a Canadian DIN record